Endocyte inc (ECYT)
Income statement / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue:
Total revenue

85

14

15

12

32

12

12

12

32

12

12

12

32

12

12

-

-

-

17,268

-

-

-

14,514

-

-

-

0

-

-

-

-

-

-

Collaboration revenue

-

14

15

-

-

12

12

12

32

12

12

12

32

12

12

12

3,903

49,168

17,268

17,274

16,599

16,483

14,514

14,454

12,414

7,812

0

-

0

0

-

-

-

Operating expenses:
Research and development

8,856

7,624

5,255

5,127

4,089

8,655

7,994

8,188

5,985

6,787

6,531

6,386

6,581

6,723

6,617

3,997

5,675

18,989

12,986

13,532

13,500

18,607

12,258

10,516

9,930

8,805

6,417

7,751

8,915

7,721

4,438

3,671

3,700

General and administrative

4,788

4,631

3,777

3,708

3,011

3,305

3,745

3,096

2,987

7,394

3,819

3,526

3,776

4,070

4,359

4,201

4,006

7,968

7,501

6,703

6,142

6,211

6,256

4,950

3,814

3,194

3,094

2,862

2,723

2,339

2,074

1,700

1,547

Acquired in-process research and development

-

-

-

-

16,493

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

13,644

12,256

9,032

8,882

23,593

11,960

11,739

11,284

8,972

14,181

10,351

9,913

10,358

10,794

10,977

8,198

9,682

26,958

20,488

20,235

19,643

24,818

18,514

15,467

13,745

12,000

9,511

10,614

11,638

10,061

6,512

5,371

5,247

Loss from operations

-13,559

-12,242

-9,016

-8,869

-23,561

-11,947

-11,727

-11,272

-8,939

-14,169

-10,338

-9,900

-10,325

-10,782

-10,964

-8,185

-5,778

22,210

-3,219

-2,961

-3,044

-8,335

-4,000

-1,012

-1,331

-4,187

-9,511

-10,423

-11,638

-10,061

-6,512

-5,371

-5,247

Other income (expense), net:
Interest income, net

959

720

412

295

264

233

235

231

232

207

189

161

152

184

152

163

161

168

84

85

111

126

139

190

96

27

13

38

35

36

19

2

1

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

280

347

350

448

490

697

218

202

Other income (expense), net

-7

-43

1

10

29

-30

3

-24

0

-0

-3

-55

171

-6

-57

-58

-57

-22

-6

-27

-107

-18

-0

-25

-3

-993

74

-18

-17

-3

2

-125

25

Net loss

-12,607

-11,564

-8,602

-8,564

-23,266

-11,744

-11,488

-11,064

-8,707

-13,962

-10,152

-9,794

-10,001

-10,604

-10,869

-8,080

-5,675

22,356

-3,141

-2,902

-3,041

-8,227

-3,861

-848

-1,239

-5,433

-9,770

-10,754

-12,069

-10,519

-7,188

-5,713

-5,422

Net income (loss) per share - basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.14

0.54

-

-

-0.08

-0.23

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per share - diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.14

0.52

-

-

-0.08

-0.23

-

-

-

-

-

-

-

-

-

-

-

Net loss per share -basic and diluted (in dollars per share)

-0.17

-0.17

-0.16

-0.15

-0.55

-0.28

-0.27

-0.26

-0.21

-0.33

-0.24

-0.23

-0.24

-0.25

-0.26

-

-

-

-0.09

-

-

-

-0.11

-

-0.03

-0.15

-0.27

-0.26

-0.36

-0.35

-0.43

-6.16

-5.93

Items included in other comprehensive income:
Unrealized gain on foreign currency translation

-

-

-

-

-

-

-

-

-

-

-

51

0

-1

0

-4

-5

-29

0

11

3

-21

0

-1

1

-1

2

-

-1

0

-

-

-

Unrealized gain on available-for-sale securities

11

44

-14

-59

30

19

-12

-72

-64

65

110

-154

51

-17

134

-64

-31

-57

-8

24

105

-98

-40

7

114

-46

1

-

-14

26

-

-

-

Other comprehensive income

11

44

-14

-59

30

19

-12

-72

-64

65

110

-102

51

-19

134

-68

-37

-86

-8

35

108

-120

-39

6

116

-47

3

-

-15

26

-

-

-

Comprehensive loss

-12,595

-11,519

-8,617

-8,623

-23,236

-11,725

-11,501

-11,137

-8,772

-13,897

-10,042

-9,896

-9,950

-10,623

-10,734

-8,149

-5,712

22,270

-3,149

-2,866

-2,932

-8,348

-3,901

-842

-1,122

-5,480

-9,766

-10,774

-12,085

-10,492

-7,185

-

-

Weighted-average number of common shares used in net income (loss) per share calculation - basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,564

41,398

-

-

36,077

35,991

-

-

-

-

-

-

-

-

-

-

-

Weighted-average number of common shares used in net income (loss) per share calculation - diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,564

43,196

-

-

36,077

35,991

-

-

-

-

-

-

-

-

-

-

-

Weighted-average number of common shares used in net loss per share calculation - basic and diluted (in shares)

72,043

69,712

55,000

48,026

42,636

42,503

42,434

42,290

42,263

42,178

42,109

41,986

41,974

41,939

41,857

-

-

-

36,193

-

-

-

35,930

-

35,881

35,843

35,798

36,000

33,414

29,693

16,907

927

914